Market capitalization | $66.00m |
Enterprise Value | $41.15m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 128.59 |
P/S ratio (TTM) P/S ratio | 206.25 |
P/B ratio (TTM) P/B ratio | 2.20 |
Revenue growth (TTM) Revenue growth | -99.38% |
Revenue (TTM) Revenue | $320.00k |
As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.
1 Analyst has issued a forecast Happiness Biotech Group Ltd:
1 Analyst has issued a forecast Happiness Biotech Group Ltd:
Sep '24 |
+/-
%
|
||
Revenue | 0.32 0.32 |
99%
99%
|
|
Gross Profit | -0.53 -0.53 |
121%
121%
|
|
EBITDA | -2.26 -2.26 |
95%
95%
|
EBIT (Operating Income) EBIT | -1.51 -1.51 |
97%
97%
|
Net Profit | -28 -28 |
37%
37%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Happiness Biotech Group Ltd. is a nutraceutical and dietary supplements producer, which engages in the research, development, manufacturing, marketing, and sales of a variety of products made from herbal and animal extracts. The firm's products include lucidum spore powder; cordyceps mycelia; ijiao solution; and American ginseng. It operates under the brand name Happiness. The company was founded on February 9, 2018 and is headquartered in Nanping City, China.
Head office | Cayman Islands |
CEO | Xiao Zhang |
Employees | 11 |
Founded | 2018 |
Website | www.pavs.ai |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.